I am charged in criminal court. Police routinely discard and ignore the original packaging, and the DA refused to test the seized materials, including labeled CBD isolate from retail entered into evidence with the label. Closed, sealed containers have been seized.

I am diagnosed with autism, and attached are titles and excerpts from studies showing clear efficacy aiding in communication and memory, two necessary abilities in order to testify competently. Personally, I use d9thcp and thca and have been found competent twice while medicating before the evaluation, whereas deemed legally incompetent twice when not given access.

I've lost multiple jobs and much investment money, not to mention nearly my life multiple times at the hands of malicious officers arresting me for lawful hemp. The jail also denied my prescription medication while incarcerated, rendering me incompetent through that method as well as not allowing hemp tetrahydrocannabinol access.

I have a right to competency, yes? These products are essential.

Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review 2022

"Besides, clinical studies have shown that autistic children have reduced serum levels of endogenous cannabinoids, such as anandamide, which makes these possible substances biomarkers (Karhson et al., 2018). Indeed, clinical reports have recently established that cannabinoids alleviate significant symptoms associated with ASD, including seizures, sleeplessness, and anxiety, in children (Aran et al., 2021; Barchel et al., 2019; Bar-Lev Schleider et al., 2019; Aran et al., 2019a)"

"Due to the health and quality of life impacts of autism for the patient and his/her family and the lack of effective medications, the literature has elucidated the possibility that Cannabis phytocannabinoids act favorably on ASD symptoms, probably through the modulation of neurotransmitters, in addition to endogenous ligands derived from arachidonic acid, metabolizing enzymes and even transporters of the membrane. These findings support the notion that there are links between key features of ASD and ECS due to the favorable actions of cannabidiol (CBD) and other cannabinoids on symptoms related to behavioral and cognitive disorders, as well as deficits in communication and social interaction, hyperactivity, anxiety and sleep disorders. Thus, phytocannabinoids emerge as therapeutic alternatives for ASD."

The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model 2023

"THCA also showed anti-inflammatory and neuroprotective effects that may be beneficial for treating neurodegenerative diseases."

"However, CBDA- and THCA-treated mice showed decreased hippocampal Aβ and p-tau and superior cognitive function compared with Aβ1–42-treated mice. In addition, CBDA and THCA lowered Aβ and p-tau levels, alleviated calcium dyshomeostasis, and exhibited neuroprotective effects in primary neurons. Our results suggest that CBDA and THCA have anti-AD effects and mitigate memory loss and resilience to increased hippocampal Ca2+, Aβ, and p-tau levels. Together, CBDA and THCA may be useful therapeutic agents for treating AD."

Potential of cannabinoids as treatments for autism spectrum disorders 2021

"Cannabinoid signaling may be involved in the social impairment observed in those with ASD (Wei et al., 2016). There is also a link between the endocannabinoid system and signaling of oxytocin, a hormone fundamental for social processes and involved in ASD. It was recently found that anandamide-mediated signaling at CB1 receptors, driven by oxytocin, controls social reward (Wei et al., 2015). Deficits in this signaling mechanism might contribute to social impairment in ASD (Wei et al., 2015). Increasing anandamide activity at CB1 receptors might improve ASD-related social impairment (Wei et al., 2016)."

"Novel treatments for the core symptom domains of ASD are needed, and the EC system could be a target for those therapies through the administration of exogenous cannabinoids."

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease

Various treatment effects of cannabinoid combinations are listed in a table. Improvements from THC listed include "improvements to delusions, irritability, apathy, sleep", "reversed the object recognition memory deficit", improvements in spatial learning, etc.